Suppr超能文献

影响肌萎缩侧索硬化症患者纵向功能衰退和生存的因素。

Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.

作者信息

Watanabe Hazuki, Atsuta Naoki, Nakamura Ryoichi, Hirakawa Akihiro, Watanabe Hirohisa, Ito Mizuki, Senda Jo, Katsuno Masahisa, Izumi Yuishin, Morita Mitsuya, Tomiyama Hiroyuki, Taniguchi Akira, Aiba Ikuko, Abe Koji, Mizoguchi Kouichi, Oda Masaya, Kano Osamu, Okamoto Koichi, Kuwabara Satoshi, Hasegawa Kazuko, Imai Takashi, Aoki Masashi, Tsuji Shoji, Nakano Imaharu, Kaji Ryuji, Sobue Gen

机构信息

Department of Neurology.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):230-6. doi: 10.3109/21678421.2014.990036. Epub 2014 Dec 30.

Abstract

Our objective was to elucidate the clinical factors affecting functional decline and survival in Japanese amyotrophic lateral sclerosis (ALS) patients. We constructed a multicenter prospective ALS cohort that included 451 sporadic ALS patients in the analysis. We longitudinally utilized the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) as the functional scale, and determined the timing of introduction of a tracheostomy for positive-pressure ventilation and death. A joint modelling approach was employed to identify prognostic factors for functional decline and survival. Age at onset was a common prognostic factor for both functional decline and survival (p < 0.001, p < 0.001, respectively). Female gender (p = 0.019) and initial symptoms, including upper limb weakness (p = 0.010), lower limb weakness (p = 0.008) or bulbar symptoms (p = 0.005), were related to early functional decline, whereas neck weakness as an initial symptom (p = 0.018), non-use of riluzole (p = 0.030) and proximal dominant muscle weakness in the upper extremities (p = 0.01) were related to a shorter survival time. A decline in the ALSFRS-R score was correlated with a shortened survival time (p < 0.001). In conclusion, the factors affecting functional decline and survival in ALS were common in part but different to some extent. This difference has not been previously well recognized but is informative in clinical practice and for conducting trials.

摘要

我们的目标是阐明影响日本肌萎缩侧索硬化症(ALS)患者功能衰退和生存的临床因素。我们构建了一个多中心前瞻性ALS队列,分析中纳入了451例散发性ALS患者。我们纵向使用修订后的肌萎缩侧索硬化症功能评定量表(ALSFRS-R)作为功能量表,并确定进行气管切开以实施正压通气的时间和死亡时间。采用联合建模方法来确定功能衰退和生存的预后因素。发病年龄是功能衰退和生存的共同预后因素(分别为p < 0.001,p < 0.001)。女性(p = 0.019)以及包括上肢无力(p = 0.010)、下肢无力(p = 0.008)或延髓症状(p = 0.005)在内的初始症状与早期功能衰退相关,而作为初始症状的颈部无力(p = 0.018)、未使用利鲁唑(p = 0.030)和上肢近端为主的肌肉无力(p = 0.01)与较短的生存时间相关。ALSFRS-R评分下降与生存时间缩短相关(p < 0.001)。总之,影响ALS患者功能衰退和生存的因素部分相同,但在一定程度上有所不同。这种差异此前尚未得到充分认识,但在临床实践和开展试验方面具有参考价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验